Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Healthtrust
Merck
QuintilesIMS
Mallinckrodt
Boehringer Ingelheim
Baxter
US Department of Justice
Federal Trade Commission
Teva

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075808

« Back to Dashboard
NDA 075808 describes TRI-SPRINTEC, which is a drug marketed by Barr and is included in one NDA. It is available from seven suppliers. Additional details are available on the TRI-SPRINTEC profile page.

The generic ingredient in TRI-SPRINTEC is ethinyl estradiol; norgestimate. There are twenty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.

Summary for NDA: 075808

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 075808

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRI-SPRINTEC
ethinyl estradiol; norgestimate
TABLET;ORAL-28 075808 ANDA Teva Pharmaceuticals USA, Inc. 0555-9018 0555-9018-58 6 POUCH in 1 CARTON (0555-9018-58) > 1 BLISTER PACK in 1 POUCH > 1 KIT in 1 BLISTER PACK
TRI-SPRINTEC
ethinyl estradiol; norgestimate
TABLET;ORAL-28 075808 ANDA Rebel Distributors Corp 21695-770 21695-770-01 1 BLISTER PACK in 1 POUCH (21695-770-01) > 1 KIT in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG
Approval Date:Dec 29, 2003TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Dow
Colorcon
Argus Health
Daiichi Sankyo
Teva
Fuji
QuintilesIMS
Farmers Insurance
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot